Table 1.
emographic information, risk factors and testing information of Indiana cases with HCV and HIV infection.
| Variable demographics | Total patients (N = 492)a |
|---|---|
| Reason for testing | Number |
| Injection drug user | 274 |
| Recent exposure | 153 |
| Past exposure | 7 |
| Correctional screening | 23 |
| Routine screening | 8 |
| Confirmatory | 3 |
| Not available/unknown | 24 |
| Race | |
| White | 474 |
| Other or missing data | 18 |
| Sex | |
| Male | 313 |
| Female | 179 |
| County | |
| Scott | 295 |
| Clark | 64 |
| Jackson | 65 |
| Other | 68 |
| Age (years) | |
| <25 | 92 |
| 25–34 | 212 |
| 35–44 | 113 |
| ≥45 | 75 |
| HCV molecular data | |
| HCV RNA positive | 359 |
| HIV Co-infected HCV RNA positive | 91 |
| NS5B sanger sequencing | 299 |
| HVR1 NG sequencing | 281 |
| Sanger and/or NG sequencing | 329 |
| HCV RNA positive, no sequencing results | 20 |
| HCV Ab positive, PCR negative | 38 |
| Acute HCV cases | 12 |
| Reference HCV cases from 2010 | 10 |
a
Samples include anti-HCV and/or anti-HIV, anti-HCV and/or HCV RNA positive.